Guillermo: How timely. I just read your excellent article this past weekend (Porta et al), and it was excellent. I highly recommend all rheumatologists and APPs who treat SLE patients to read it. Print out figure 3 from the article and pin it up somewhere. If we all did this (along with abiding by the 2023 EULAR Guidelines), there would be many more SLE patients in remission and off steroids.
Here is the reference to the article: Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues. J Clin Med. 2020 Aug 21;9(9):2709 at https://www.mdpi.com/2077-0383/9/9/2709
Guillermo: How timely. I just read your excellent article this past weekend (Porta et al), and it was excellent. I highly recommend all rheumatologists and APPs who treat SLE patients to read it. Print out figure 3 from the article and pin it up somewhere. If we all did this (along with abiding by the 2023 EULAR Guidelines), there would be many more SLE patients in remission and off steroids.
Here is the reference to the article: Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues. J Clin Med. 2020 Aug 21;9(9):2709 at https://www.mdpi.com/2077-0383/9/9/2709